Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144911
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2005-09-01
Brief Title:
ADVAIR DISKUS Inhaler Fluticasone PropionateSalmeterol Versus SEREVENT DISKUS Inhaler Salmeterol For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations ADVAIR DISKUS Inhaler and SEREVENT DISKUS Inhaler Are Trademarks of the GSK Group of Companies
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-01
First Submit QC Date:
September 1 2005
Study First Post Date:
2005-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-26
Last Update Post Date:
2016-10-28
Last Update Post Date Type:
ESTIMATED